Navigation Links
Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
Date:2/8/2008

n capital expenditures for operating-type leases and the associated depreciation."

Garrett stated, "The continued above-market growth of our clinical diagnostics business was fueled by the introduction of our new UniCel(R) DxI 600 Immunoassay system and a third straight year of record placements of the UniCel(R) DxC 600 and 800 clinical chemistry systems. Demand for our chemistry / immunoassay work cells continues at a rapid pace as demonstrated by a 20% increase in placements for the year. In Clinical Automation, placements accelerated and revenue grew almost 70%."

Full Year 2008 Outlook

The following outlook is based on 2007 adjusted results and does not include special items that may occur in 2008.

"Assuming stable currency, our outlook for full year 2008 revenue growth is 7% to 9%," Garrett continued. "Our goal for the Clinical Diagnostics business is to continue to exceed 10% revenue growth in 2008. We expect revenue from life science products to be about flat with prior year.

"Operating margin for the year should expand to around 12.5%, reflecting our commitment to operating excellence. Non-operating expense is expected to be approximately $11 to $12 million per quarter. Pretax profit growth should be between 13% to 16% and even though we expect a tax rate of 30% to 31%, earnings per diluted share should be $3.50 to $3.65. Capital expenditures are expected to be $290 to $310 million, and depreciation and amortization should be between $240 and $260 million. We expect cash flow to be strong in 2008 as it was in 2007 providing a source for share repurchase."

"In the first quarter, we expect to commercialize our next chemistry / immunoassay work cell, the UniCel(R) DxC 880i, the first of four new work cells coming in 2008. The new UniCel DxH, our next generation hematology system, should be introduced at the end of 2008, and we continue to make solid progress with the development of our DxN 'sample-to-result' instrument f
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
5. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
6. Haemacure Reports Third Quarter 2007 Results
7. Weight Watchers Declares Quarterly Dividend
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. Medical Services International Maintains Pace in Second Quarter
11. Martek Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... (PRWEB) September 16, 2014 According to a  ... David Wilson has retired after aggravating a neck injury he ... was then discovered to have spinal stenosis as well, which ... adults and can lead to symptoms such as back or ... again after surgery to repair the disc, but recently his ...
(Date:9/16/2014)... 2014 Luke Sniewski, Claire Robbie and ... 14-month journey around the world to celebrate cultural diversity ... titled ‘Million Ways to Live’, will take them to ... healthy lifestyles of amazing, unique and diverse people. , ... documentary series will focus on how individuals apply 6 ...
(Date:9/16/2014)... Norfolk, VA (September 16, 2014) – ... friendly desserts, announced today the launch of a limited ... this October. In support of the American Cancer Society, ... a charitable donation in 2014 as well as help ... cancers among women in the United States. , ...
(Date:9/16/2014)... September 16, 2014 Care Logistics® ... a component of the Hospital Operating System™ that ... patient needs with staff capacity. For the first ... of actual nursing and other staff capacity. , ... patient-care needs, anticipated admissions, discharges and transfers, real ...
(Date:9/16/2014)... Effective treatment options exist for women with urinary ... to new guidelines from the American College of ... floor muscles, bladder training and weight loss could ... urinary incontinence have problems holding in urine when ... that these women perform Kegel exercises to strengthen ...
Breaking Medicine News(10 mins):Health News:NFL Injuries Put Spotlight on Spinal Health 2Health News:NFL Injuries Put Spotlight on Spinal Health 3Health News:Launched by Luke Sniewski and Claire Robbie, Million Ways to Live is an International Documentary Series on Healthy Living in Different Cultures 2Health News:Launched by Luke Sniewski and Claire Robbie, Million Ways to Live is an International Documentary Series on Healthy Living in Different Cultures 3Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 2Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 3Health News:Care Logistics Launches Demand Logistics as Part of the Hospital Operating System 2Health News:Nonsurgical Treatments Suggested for Women's Urinary Incontinence 2
... April 3, 2008 Facial trauma,is a too ... and Congresswoman Carolyn McCarthy (D-N.Y.) hopes to raise,awareness ... a congressional,resolution (H. Res. 1062) to designate April ... http://www.newscom.com/cgi-bin/prnh/20050125/CGTU021LOGO ), An estimated 5 million ...
... G. Rendell today signed House Bill 874 into law., ... is designed to educate,pregnant women about the potential benefits ... the donation and storage of,umbilical cord blood when they ... committed to creating a first-rate public,education system, protecting our ...
... 3, 2008 MedQuist,Inc. (Pink Sheets: MEDQ.PK) ... care community hospital in Newburyport, Mass., has ... clinical documentation solution,including dictation, transcription and speech ... reports annually and is home to a,nationally ...
... 3 /PRNewswire-FirstCall/ - SXC Health Solutions, Corp.,("SXC" or the ... provider of,pharmacy benefits management services, announces that Mark Thierer,President ... will present at the,SunTrust 37th Annual Institutional Conference at ... on Tuesday, April 15,2008 at 9:40 am Eastern Time., ...
... athletes, soldiers from fatal temperature rise , , THURSDAY, April ... may have been found in a genetic disorder that causes ... body temperature, according to a new report. , ... Cell , also suggest that certain antioxidants may help protect ...
... FITCHBURG, Mass., April 3, 2008 Integrated,Pharmaceuticals, Inc. ... Inc., a distributor servicing more than six hundred ... Eastern Ohio and Western,Pennsylvania has agreed to carry ... are very pleased to carry this new and ...
Cached Medicine News:Health News:Oral and Maxillofacial Surgeons Raise Awareness About the Importance of Facial Protection 2Health News:MedQuist Technology Solutions to Power Documentation Workflow at New England Facility 2Health News:MedQuist Technology Solutions to Power Documentation Workflow at New England Facility 3Health News:Genetic Disorder May Hold Key to Heat Stroke Cure 2Health News:Genetic Disorder May Hold Key to Heat Stroke Cure 3Health News:Snack Brothers Distributors to Sell New HEALTHYCAL+ Bottled Water 2
(Date:9/16/2014)... BOSTON , September 16, 2014 ... Fiona Marshall , will give a presentation entitled " ... StaR ®   technology " ... and Development " virtual symposium run by Chemical & Engineering ... symposium is on Wednesday, 24 September 2014; Dr Marshall,s presentation ...
(Date:9/15/2014)... Sept. 15, 2014 GenomeDx Biosciences today ... the American Society for Radiation Oncology (ASTRO) Annual ... Cancer Classifier, a genomic test capable of predicting ... and improve patient outcomes for prostate cancer patients ... a recently published study that demonstrates how Decipher ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic ... provides key market data on the Spain Aesthetic ... value, in millions of US dollars, volume (in ... market segments Invasive Body Contouring Devices (Laser-Assisted Liposuction ... Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and ...
Breaking Medicine Technology:Heptares to Present on Structure-Based Drug Design Using G Protein-Coupled Receptors at Inaugural Chemistry & Engineering News Virtual Symposium 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5
... Agent Ever to Demonstrate Significant Survival Benefit ... /PRNewswire-FirstCall/ -- Bayer,HealthCare Pharmaceuticals Inc. and Onyx ... significantly,extended overall survival in patients with hepatocellular ... taking placebo by 44%,(HR=0.69; p-value=0.0006). Results were ...
... WIRE)--Jun 4, 2007 - Researchers at,Molecular Insight ... on MIP-1072, a radiolabeled, small molecule,molecular imaging ... prostate cancer at the 54th annual meeting ... Washington, D.C. MIP-1072 is,one of two development ...
Cached Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4
... for laboratories looking for time and cost ... operation in terms of easy reagent cassette ... on-board stability., ,URISYS 2400 is a ... capability for medium to high volume laboratories ...
... The Small Joint Ball Electrode ... in small joint applications. With its ... tip, controlled capsuloligamentous or tendinous tissue ... When used in conjunction with the ...
Acufex arthroscopic electrodes are insulated for use in all fluids and come in boxes of 10....
... The Assistant Free ... retractors utilizing Velcro® straps. ... of the surgeon's operative ... personnel. Three retractor styles ...
Medicine Products: